maccs banner

Agenda

Mid-Atlantic Capital Cardiology Symposium 2026

heart house

2400 N St NW, Washington, DC 20037



Speakers will be added as they are confirmed.


SATURDAY, NOVEMBER 14


5:30pm

Kick-Off Cocktail Reception

Join members in the lobby and exhibit area of Heart House to kick off MACCS. 

This is a separately ticketed event. Tickets sold through registration or via our Square Site.


7:00pm

Reception Concludes

Attendees who have signed up for the Monuments by Moonlight tour should go directly to the pick-up point.


SUNDAY, NOVEMBER 15

7:00am

Breakfast in the Exhibit Hall


 

7:55am

Welcome & Objectives 


 

8:00am


Rethinking Established Paradigms

Beta-blockers After MI: Are They Still Necessary? 

GLP-1 Receptor Agonists and Cardiovascular Outcomes: SELECT, SOUL, and Cardiometabolic Medicine 

Application of AI  in advanced Echo imaging and interpretation- debate on boundaries and advantages.

 

9:00am

Intervention Cardiology — Where Are We Now?

Tricuspid and Mitral Transcatheter Interventions: TRISCEND II and MATTERHORN 

Coronary Physiology-guided PCI: Lessons From FAVOR III and Beyond 

TAVR in Asymptomatic Severe aortic Stenosis: EARLY-TAVR and Its Implications



10:00am


BREAK

Grab a warm beverage and chat with our Exhibitors

 

10:30am

Atrial Fibrillation — Evolving Management Strategies

Device-detected Subclinical AF: When to Anticoagulate?

DEBATE: Left Atrial Appendage Closure: CLOSURE-AF and Evolving Indications

 


11:30am

ACC in Review

Fred Kusumoto, MD, FACC
Professor of Medicine
Director of the Heart Rhythm Services
Associate Dean of Faculty Affairs 
Mayo Clinic
Jacksonville, FL
Member ACC Board of Trustees

 

11:45am

LUNCH in the Exhibit Area

Visit Exhibitors & State of Art Technology Showcases in Conference Rooms


 

1:00pm


Heart Failure and Cardiomyopathy — New Therapies Across the Spectrum 

Iron Deficiency in Heart Failure: From IRONMAN to INFERRCT 

Cardiac Myosin Inhibitors for Obstructive HCM: Mavacamten, Aficamten (SEQUOIA-HCM), and MAPLE-HCM 

ATTR Cardiac Amyloid: HELIOS-B, Acoramidis, and the Expanding Treatment Landscape

 

2:00pm

Preventive Cardiology — Novel Therapeutics and Risk Reduction

Menopause and CV Risk

Cholesterol Review of New Cholesterol Guidelines

The Status of Lp(a) Therapy


 

3:00pm

ADJOURN 




Powered by Wild Apricot Membership Software